Lakshmi Rangachari

Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease

Marc Nicolino, Barry J. Byrne, J. Edmund Wraith et al. · Genetics in Medicine · 2009 · 290 citations · Full text

Pediatric Epidemiology, Clinical Epidemiology, Pediatrics +7

Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry

Kristin D׳Aco, Lisa H. Underhill, Lakshmi Rangachari et al. · European Journal of Pediatrics · 2012 · 100 citations · Full text

High rate of postoperative mortality in patients with mucopolysaccharidosis I: findings from the MPS I Registry

Pamela Arn, Chester Whitley, J. E. Wraith et al. · Journal of Pediatric Surgery · 2012 · 35 citations

High Rate, Patient Safety, Outcomes Research +3

Effects of rifampin, itraconazole and esomeprazole on the pharmacokinetics of alisertib, an investigational aurora a kinase inhibitor in patients with advanced malignancies

Xiaofei Zhou, Shubham Pant, John Nemunaitis et al. · Investigational New Drugs · 2017 · 19 citations · Full text

Phase I study of the investigational, oral pan-RAF kinase inhibitor TAK-580 (MLN2480) in patients with advanced solid tumors (ST) or melanoma (MEL): Final analysis

Anthony J. Olszanski, René González, Pippa Corrie et al. · Annals of Oncology · 2017 · 12 citations · Full text

Tumor Biology, Oncology, Medicine +9